Healthcare provider profile · identity verified

William H Baird, M.D.

Internal Medicine · PRAIRIEVILLE, LA · NPI 1770515413

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	663	197
Amlodipine Besylate	Amlodipine Besylate	402	122
Levothyroxine Sodium	Levothyroxine Sodium	319	81
Metformin Hcl	Metformin Hcl	266	82
Losartan Potassium	Losartan Potassium	260	74
Pantoprazole Sodium	Pantoprazole Sodium	247	73
Metoprolol Succinate	Metoprolol Succinate	242	64
Escitalopram Oxalate	Escitalopram Oxalate	210	52
Gabapentin	Gabapentin	200	50
Lisinopril	Lisinopril	186	58
Meloxicam	Meloxicam	183	52
Omeprazole	Omeprazole	183	57
Pravastatin Sodium	Pravastatin Sodium	182	49
Tamsulosin Hcl	Tamsulosin Hcl	158	45
Hydrochlorothiazide	Hydrochlorothiazide	146	40
Rosuvastatin Calcium	Rosuvastatin Calcium	145	43
Simvastatin	Simvastatin	137	39
Metformin Hcl Er	Metformin Hcl	117	33
Alprazolam	Alprazolam	111	26
Clopidogrel	Clopidogrel Bisulfate	102	29
Fluticasone Propionate	Fluticasone Propionate	91	46
Metoprolol Tartrate	Metoprolol Tartrate	86	28
Trazodone Hcl	Trazodone Hcl	84	23
Famotidine	Famotidine	81	26
Finasteride	Finasteride	81	23
Furosemide	Furosemide	81	30
Jardiance	Empagliflozin	81	21
Bupropion Xl	Bupropion Hcl	75	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	23
Alendronate Sodium	Alendronate Sodium	72	21
Celecoxib	Celecoxib	70	19
Sertraline Hcl	Sertraline Hcl	69	23
Clonazepam	Clonazepam	68	suppressed
Trulicity	Dulaglutide	68	16
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	67	16
Zolpidem Tartrate	Zolpidem Tartrate	67	11
Potassium Chloride	Potassium Chloride	61	22
Eliquis	Apixaban	60	13
Allopurinol	Allopurinol	59	18
Esomeprazole Magnesium	Esomeprazole Magnesium	59	13
Lorazepam	Lorazepam	58	suppressed
Donepezil Hcl	Donepezil Hcl	57	12
Fenofibrate	Fenofibrate	57	15
Temazepam	Temazepam	55	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	54	14
Olmesartan Medoxomil	Olmesartan Medoxomil	54	17
Mounjaro	Tirzepatide	53	14
Montelukast Sodium	Montelukast Sodium	48	17
Warfarin Sodium	Warfarin Sodium	47	suppressed
Primidone	Primidone	46	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	45	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	45	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	16
Glimepiride	Glimepiride	41	13
Buspirone Hcl	Buspirone Hcl	39	suppressed
Ozempic	Semaglutide	39	suppressed
Carvedilol	Carvedilol	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Repatha Sureclick	Evolocumab	32	suppressed
Spironolactone	Spironolactone	32	suppressed
Atenolol	Atenolol	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	11
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Baclofen	Baclofen	26	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	26	suppressed
Rybelsus	Semaglutide	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Synthroid	Levothyroxine Sodium	23	11
Xarelto	Rivaroxaban	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Digoxin	Digoxin	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Valsartan	Valsartan	20	suppressed
Estradiol	Estradiol	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Glipizide	Glipizide	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	18	suppressed
Irbesartan	Irbesartan	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Tiadylt Er	Diltiazem Hcl	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error